Table 4.
Closure method | Male | Female | p‐value |
---|---|---|---|
Manual compression | |||
Any 72‐h bleeding | 41/2613 (1.6%) | 66/1482 (4.5%) | < 0.001 |
Access site bleeding | 9/2613 (0.3%) | 25/1482 (1.7%) | < 0.001 |
Hematoma | 7/2613 (0.3%) | 32/1482 (2.2%) | < 0.001 |
Retroperitoneal bleed | 1/2613 (0.04%) | 11/1482 (0.7%) | < 0.001 |
Vascular complication | 8/2613 (0.3%) | 12/1482 (0.8%) | 0.020 |
Any closure device | |||
Any 72‐h bleeding | 39/4903 (0.8%) | 44/2444 (1.8%) | < 0.001 |
Access site bleeding | 8/4903 (0.2%) | 18/2444 (0.8%) | < 0.001 |
Hematoma | 10/4903 (0.2%) | 19/2444 (0.8%) | < 0.001 |
Retroperitoneal bleed | 5/4903 (0.1%) | 8/2444 (0.3%) | 0.031 |
Vascular complication | 9/4903 (0.2%) | 5/2444 (0.2%) | 0.846 |
Angioseal | |||
Any 72‐h bleeding | 24/2411 (1.0%) | 20/1166 (1.7%) | 0.071 |
Access site bleeding | 4/2411 (0.2%) | 7/1166 (0.6%) | 0.028 |
Hematoma | 4/2411 (0.2%) | 8/1166 (0.7%) | 0.012 |
Retroperitoneal bleed | 3/2411 (0.1%) | 4/1166 (0.3%) | 0.166 |
Vascular complication | 6/2411 (0.2%) | 1/1166 (0.1%) | 0.302 |
Suture based closure | |||
Any 72‐h bleeding | 3/1040 (0.3%) | 9/424 (2.1%) | < 0.001 |
Access site bleeding | 0/1040 (0.0%) | 6/424 (1.4%) | N/A |
Hematoma | 0/1040 (0.0%) | 2/424 (0.5%) | N/A |
Retroperitoneal bleed | 0/1040 (0.0%) | 0/424 (0.0%) | N/A |
Vascular complication | 0/1040 (0.0%) | 1/424 (0.2%) | N/A |
Mynx | |||
Any 72‐h bleeding | 12/1452 (0.8%) | 15/854 (1.8%) | 0.048 |
Access site bleeding | 4/1452 (0.3%) | 5/854 (0.6%) | 0.251 |
Hematoma | 6/1452 (0.4%) | 9/854 (1.1%) | 0.067 |
Retroperitoneal bleed | 2/1452 (0.1%) | 4/854 (0.5%) | 0.133 |
Vascular complication | 3/1452 (0.2%) | 3/854 (0.4%) | 0.511 |